Clinical Trial Update: NT-501 CNTF Implant for Ischemic Optic Neuropathy: Safety, Neuroprotection and Neuroenhancement [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update assessing the safety, neuroprotection, and potential neuroenhancement of the NT-501 CNTF implant in ischemic optic neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Optic Neuropathy

Drugs mentioned

• NT-501 CNTF implant (CNTF implant)

Snippet

Sponsor: Jeffrey L Goldberg | Conditions: Ischemic Optic Neuropathy/Optic Nerve Stroke | Phase 1 | Status: COMPLETED